Demethylated Drug in the Treatment of Nasopharyngeal Carcinoma
Condition(s):Nasopharyngeal CarcinomaLast Updated:October 10, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):Nasopharyngeal CarcinomaLast Updated:October 10, 2018Unknown status
Condition(s):Nasopharyngeal Carcinoma; Radiation-Induced Temporal Lobe InjuryLast Updated:February 6, 2024Completed
Condition(s):Nasopharyngeal CarcinomaLast Updated:November 8, 2019Unknown status
Condition(s):Nasopharyngeal CarcinomaLast Updated:June 8, 2021Not yet recruiting
Condition(s):Nasopharyngeal CarcinomaLast Updated:March 24, 2020Unknown status
Condition(s):Salivary Gland Cancer; Nasopharyngeal CarcinomaLast Updated:April 3, 2015Unknown status
Condition(s):Nasopharyngeal CarcinomaLast Updated:November 18, 2021Recruiting
Condition(s):Nasopharyngeal Carcinoma; Oral MucositisLast Updated:January 5, 2024Recruiting
Condition(s):Nasopharyngeal CarcinomaLast Updated:February 28, 2024Recruiting
Condition(s):Nasopharyngeal CarcinomaLast Updated:May 22, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.